{"schema_version":"alpha-company-profile-public-v2","slug":"lexeo-therapeutics-inc","canonical_url":"https://registry.alpha.ac/companies/lexeo-therapeutics-inc","published_on":"2026-10-06T04:46:47.792621+00:00","last_reviewed_on":"2026-10-06T04:46:47.792621+00:00","identity":{"legal_name":"Lexeo Therapeutics, Inc.","display_name":"Lexeo Therapeutics, Inc.","headline":"Canonical company identity and public leadership record.","description":"Alpha's canonical identity and public leadership record for Lexeo Therapeutics, Inc..","ten_second_view":"This Company Profile publishes only Alpha's canonical identity and evidence-backed public leadership records. Unavailable fields are not inferred.","legal_form":"Not publicly asserted","incorporation":"Not publicly asserted","headquarters":"US","headquarters_address":{"locality":"Not publicly asserted","region":null,"country":"US"},"operating_presence":["US"],"website":"","cik":"0001907108","logo":"https://cdn.brandfetch.io/ticker/lxeo/theme/dark/fallback/404/type/logo?c=1idgAB6rG5KFT5I7q5w","logo_source":"brandfetch","profile_mark":{"src":"https://cdn.brandfetch.io/ticker/lxeo/theme/dark/fallback/404/type/logo?c=1idgAB6rG5KFT5I7q5w","alt":"Lexeo Therapeutics, Inc. logo","width":256,"height":256,"source":"brandfetch"}},"entity_status":{"ownership_type":"unknown","listing_status":"listed","label":"Public listing published","explanation":"The canonical public record includes at least one active security listing.","source_id":"alpha-canonical-company-record","reviewed_on":"2026-10-06T04:46:47.792621+00:00"},"security_listings":[{"ticker":"LXEO","exchange":"NASDAQ","exchange_display":"NASDAQ","mic":"XNAS","currency":"Unavailable","security_type":"equity","listing_status":"active","is_primary":true,"source_id":"alpha-canonical-company-record"}],"market_data":{"availability":"unavailable","endpoint":null,"source_label":null,"explanation":"Market data is not published in this Company Profile."},"profile_tags":["Canonical identity","Public leadership"],"trust_summary":"Canonical identity published; broader company intelligence is not asserted.","facts":[{"label":"Legal name","value":"Lexeo Therapeutics, Inc.","source_id":"alpha-canonical-company-record"},{"label":"Country","value":"US","source_id":"alpha-canonical-company-record"}],"operating_model":{"eyebrow":"Operating record","title":"Published operating structure","units":[]},"governance":{"summary":"Only current, confirmed leadership roles with public evidence are included in the canonical projection.","boundary":"Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","disclosures":[]},"alpha_opinion":{"status":"Not published","label":"No Alpha opinion published","explanation":"This identity record is not an Alpha rating, score, or investment opinion."},"report":{"status":"Not published","label":"No governed report published","explanation":"No governed company report is attached to this profile.","href":null},"actions":[],"related_records":[],"evidence":[{"id":"alpha-canonical-company-record","label":"Alpha canonical company public projection","href":"/api/public/companies/lexeo-therapeutics-inc","source_type":"canonical_identity","supports":["Company identity","Published leadership","Entity status boundary"],"status":"published","reviewed_on":"2026-10-06T04:46:47.792621+00:00"}],"permissions":[{"label":"Public retrieval","allowed":true},{"label":"Agent retrieval","allowed":true},{"label":"Redistribution","allowed":false},{"label":"Model training","allowed":false},{"label":"Relationship pathfinding","allowed":false},{"label":"Direct contact","allowed":false}],"limitations":["Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"financials":{"kind":"financials","records":[],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"},"ownership":{"kind":"ownership","records":[],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented. 13F and N-PX are not beneficial ownership and are never projected here.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":26,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":26,"under_review_claim_count":1,"owner_supplied_claim_count":0,"evidence_record_count":9,"distinct_source_count":3,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":26,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":26,"corroborated_claims":0,"sources":9,"distinct_sources":3,"role_claims":0,"last_reviewed_at":"2026-10-06T04:46:47.792621+00:00","observed_at":"2026-10-06T04:46:47.792621+00:00","freshness_days":0}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"company","slug":"lexeo-therapeutics-inc","canonical_url":"https://registry.alpha.ac/companies/lexeo-therapeutics-inc"},"publication":{"published_at":"2026-10-06T04:46:47.792621+00:00","last_reviewed_at":"2026-10-06T04:46:47.792621+00:00","as_of":"2026-10-06T04:46:47.792621+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/companies/lexeo-therapeutics-inc","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/companies/lexeo-therapeutics-inc","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/companies/lexeo-therapeutics-inc.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}},"canonical_profile":{"schema_version":"alpha-company-profile-public-v1","slug":"lexeo-therapeutics-inc","canonical_url":"https://registry.alpha.ac/companies/lexeo-therapeutics-inc","as_of":"2026-10-06T04:46:47.792621+00:00","last_reviewed_at":"2026-10-06T04:46:47.792621+00:00","identity":{"legal_name":"Lexeo Therapeutics, Inc.","display_name":"Lexeo Therapeutics, Inc.","description":null,"jurisdiction":null,"country":"US","sector":null,"industry":null,"website":null,"website_provenance":null,"logo_url":null,"logo_media":null,"status":"active","cik":"0001907108","entity_subtype":null,"legal_entity_status":null},"security_listings":[{"mic":"XNAS","ticker":"LXEO","currency":null,"exchange":"NASDAQ","sort_key":0,"valid_to":null,"confidence":0.95,"is_primary":true,"listing_id":"7d21f07c-bce9-4639-9a57-32270239585a","source_url":"https://www.sec.gov/files/company_tickers_exchange.json","valid_from":null,"observed_at":"2026-07-11T00:28:32+00:00","source_name":"sec_company_tickers_exchange","source_tier":1,"exchange_name":"NASDAQ","security_type":"equity","listing_status":"active","last_checked_at":"2026-09-02T01:48:40.989053+00:00"}],"market_data":{"availability":"unavailable","endpoint":null,"source_label":null,"explanation":"Market observations are unpublished. Listing identity remains available from the governed source set."},"index_memberships":[],"index_membership_history":[],"index_membership_contract":{"schema_version":"alpha-index-membership-public-v1","as_of_date":"2026-10-06","tracked_universe_complete":false,"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false},"limitations":["Only source-backed memberships with an explicit public redistribution basis are returned.","Absence from Alpha tracked indices does not establish absence from every market index.","Provider announcements and effective membership are represented as distinct states.","Alpha AI 100 is not published as a current public index membership."]},"leadership":{"board":[{"person_slug":"steven-altschuler-m-d","display_name":"Steven Altschuler, M.D.","role_category":"director","title":"Chairman of the Board","committee":null,"is_board_chair":true,"is_independent":true,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001193125-26-193930","source_url":"https://www.sec.gov/Archives/edgar/data/1907108/000119312526193930/lxeo-def_14a-2026_proxy.htm","source_type":"sec_def_14a","published_at":"2026-04-30T00:00:00+00:00","effective_date":"2026-04-30","last_checked_at":"2026-09-06T09:55:36.142416+00:00"},"headshot_url":null},{"person_slug":"brenda-cooperstone-lxeo","display_name":"Brenda Cooperstone","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2023-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A lxeo-def_14a-2026_proxy.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1907108/000119312526193930/lxeo-def_14a-2026_proxy.htm","source_type":"sec_proxy","published_at":"2026-04-30T00:00:00+00:00","effective_date":"2026-04-30","last_checked_at":"2026-09-02T01:16:32.429079+00:00"},"headshot_url":null},{"person_slug":"brenda-cooperstone-m-d-lexeo-therapeutics-inc","display_name":"Brenda Cooperstone, M.D.","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001193125-26-193930","source_url":"https://www.sec.gov/Archives/edgar/data/1907108/000119312526193930/lxeo-def_14a-2026_proxy.htm","source_type":"sec_def_14a","published_at":"2026-04-30T00:00:00+00:00","effective_date":"2026-04-30","last_checked_at":"2026-09-06T09:55:36.142416+00:00"},"headshot_url":null},{"person_slug":"laura-sepp-lorenzino-lxeo","display_name":"Laura Sepp-Lorenzino","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A lxeo-def_14a-2026_proxy.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1907108/000119312526193930/lxeo-def_14a-2026_proxy.htm","source_type":"sec_proxy","published_at":"2026-04-30T00:00:00+00:00","effective_date":"2026-04-30","last_checked_at":"2026-09-02T01:16:32.429079+00:00"},"headshot_url":null},{"person_slug":"laura-sepp-lorenzino-ph-d","display_name":"Laura Sepp-Lorenzino, Ph.D.","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001193125-26-193930","source_url":"https://www.sec.gov/Archives/edgar/data/1907108/000119312526193930/lxeo-def_14a-2026_proxy.htm","source_type":"sec_def_14a","published_at":"2026-04-30T00:00:00+00:00","effective_date":"2026-04-30","last_checked_at":"2026-09-06T09:55:36.142416+00:00"},"headshot_url":null},{"person_slug":"mette-kirstine-agger-lxeo","display_name":"Mette Kirstine Agger","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2020-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A lxeo-def_14a-2026_proxy.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1907108/000119312526193930/lxeo-def_14a-2026_proxy.htm","source_type":"sec_proxy","published_at":"2026-04-30T00:00:00+00:00","effective_date":"2026-04-30","last_checked_at":"2026-09-02T01:16:32.429079+00:00"},"headshot_url":null},{"person_slug":"paula-hj-cholmondeley-lxeo","display_name":"Paula HJ Cholmondeley","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2021-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A lxeo-def_14a-2026_proxy.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1907108/000119312526193930/lxeo-def_14a-2026_proxy.htm","source_type":"sec_proxy","published_at":"2026-04-30T00:00:00+00:00","effective_date":"2026-04-30","last_checked_at":"2026-09-02T01:16:32.429079+00:00"},"headshot_url":null},{"person_slug":"r-nolan-townsend-lxeo","display_name":"R. Nolan Townsend","role_category":"director","title":"Chief Executive Officer and Director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001193125-26-193930","source_url":"https://www.sec.gov/Archives/edgar/data/1907108/000119312526193930/lxeo-def_14a-2026_proxy.htm","source_type":"sec_def_14a","published_at":"2026-04-30T00:00:00+00:00","effective_date":"2026-04-30","last_checked_at":"2026-09-06T09:55:36.142416+00:00"},"headshot_url":null},{"person_slug":"reinaldo-diaz-lxeo","display_name":"Reinaldo Diaz","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2005-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A lxeo-def_14a-2026_proxy.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1907108/000119312526193930/lxeo-def_14a-2026_proxy.htm","source_type":"sec_proxy","published_at":"2026-04-30T00:00:00+00:00","effective_date":"2026-04-30","last_checked_at":"2026-09-02T01:16:32.429079+00:00"},"headshot_url":null},{"person_slug":"steven-altschuler-lxeo","display_name":"Steven Altschuler","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2012-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A lxeo-def_14a-2026_proxy.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1907108/000119312526193930/lxeo-def_14a-2026_proxy.htm","source_type":"sec_proxy","published_at":"2026-04-30T00:00:00+00:00","effective_date":"2026-04-30","last_checked_at":"2026-09-02T01:16:32.429079+00:00"},"headshot_url":null},{"person_slug":"tim-van-hauwermeiren-lxeo","display_name":"Tim Van Hauwermeiren","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2024-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A lxeo-def_14a-2026_proxy.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1907108/000119312526193930/lxeo-def_14a-2026_proxy.htm","source_type":"sec_proxy","published_at":"2026-04-30T00:00:00+00:00","effective_date":"2026-04-30","last_checked_at":"2026-09-02T01:16:32.429079+00:00"},"headshot_url":null},{"person_slug":"tolga-tanguler-lxeo","display_name":"Tolga Tanguler","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2024-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A lxeo-def_14a-2026_proxy.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1907108/000119312526193930/lxeo-def_14a-2026_proxy.htm","source_type":"sec_proxy","published_at":"2026-04-30T00:00:00+00:00","effective_date":"2026-04-30","last_checked_at":"2026-09-02T01:16:32.429079+00:00"},"headshot_url":null}],"executives":[{"person_slug":"eric-adler-m-d-lxeo","display_name":"Eric Adler, M.D.","role_category":"executive","title":"Chief Medical Officer and Head of Research","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.94,"evidence":{"document_title":"LXEO executive roster source","source_url":null,"source_type":"sec_filing","published_at":null,"effective_date":"2026-05-03","last_checked_at":"2026-05-03T15:43:29.420225+00:00"},"headshot_url":null},{"person_slug":"jenny-r-robertson-j-d-lxeo","display_name":"Jenny R. Robertson, J.D.","role_category":"executive","title":"Chief Legal Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.94,"evidence":{"document_title":"LXEO executive roster source","source_url":null,"source_type":"sec_filing","published_at":null,"effective_date":"2026-05-03","last_checked_at":"2026-05-03T15:43:29.420225+00:00"},"headshot_url":null},{"person_slug":"jose-manuel-otero","display_name":"Jose Manuel Otero","role_category":"executive","title":"Chief Operating Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-30","end_date":null,"verification_status":"confirmed","confidence":0.94,"evidence":{"document_title":"LXEO DEF 14A executive officers","source_url":"https://www.sec.gov/Archives/edgar/data/1907108/000119312526193930/lxeo-def_14a-2026_proxy.htm","source_type":"sec_filing","published_at":"2026-04-30T00:00:00+00:00","effective_date":"2026-04-30","last_checked_at":"2026-05-15T03:29:12.418198+00:00"},"headshot_url":null},{"person_slug":"jose-manuel-otero-ph-d-lxeo","display_name":"Jose Manuel Otero, Ph.D.","role_category":"executive","title":"Chief Operating Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001193125-26-193930","source_url":"https://www.sec.gov/Archives/edgar/data/1907108/000119312526193930/lxeo-def_14a-2026_proxy.htm","source_type":"sec_def_14a","published_at":"2026-04-30T00:00:00+00:00","effective_date":"2026-04-30","last_checked_at":"2026-09-06T09:55:36.142416+00:00"},"headshot_url":null},{"person_slug":"kyle-rasbach-ph-d-lxeo","display_name":"Kyle Rasbach, Ph.D.","role_category":"executive","title":"Chief Financial Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.94,"evidence":{"document_title":"LXEO executive roster source","source_url":null,"source_type":"sec_filing","published_at":null,"effective_date":"2026-05-03","last_checked_at":"2026-05-03T15:43:29.420225+00:00"},"headshot_url":null},{"person_slug":"louis-tamayo","display_name":"Louis Tamayo","role_category":"executive","title":"Chief Financial Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001193125-26-193930","source_url":"https://www.sec.gov/Archives/edgar/data/1907108/000119312526193930/lxeo-def_14a-2026_proxy.htm","source_type":"sec_def_14a","published_at":"2026-04-30T00:00:00+00:00","effective_date":"2026-04-30","last_checked_at":"2026-09-06T09:55:36.142416+00:00"},"headshot_url":null},{"person_slug":"narinder-bhalla-m-d","display_name":"Narinder Bhalla, M.D.","role_category":"executive","title":"Chief Medical Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001193125-26-193930","source_url":"https://www.sec.gov/Archives/edgar/data/1907108/000119312526193930/lxeo-def_14a-2026_proxy.htm","source_type":"sec_def_14a","published_at":"2026-04-30T00:00:00+00:00","effective_date":"2026-04-30","last_checked_at":"2026-09-06T09:55:36.142416+00:00"},"headshot_url":null},{"person_slug":"narinder-p-bhalla","display_name":"Narinder P. Bhalla","role_category":"executive","title":"Chief Medical Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-30","end_date":null,"verification_status":"confirmed","confidence":0.94,"evidence":{"document_title":"LXEO DEF 14A executive officers","source_url":"https://www.sec.gov/Archives/edgar/data/1907108/000119312526193930/lxeo-def_14a-2026_proxy.htm","source_type":"sec_filing","published_at":"2026-04-30T00:00:00+00:00","effective_date":"2026-04-30","last_checked_at":"2026-05-15T03:29:11.927287+00:00"},"headshot_url":null},{"person_slug":"r-nolan-townsend-lxeo","display_name":"R. Nolan Townsend","role_category":"executive","title":"Chief Executive Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001193125-26-193930","source_url":"https://www.sec.gov/Archives/edgar/data/1907108/000119312526193930/lxeo-def_14a-2026_proxy.htm","source_type":"sec_def_14a","published_at":"2026-04-30T00:00:00+00:00","effective_date":"2026-04-30","last_checked_at":"2026-09-06T09:55:36.142416+00:00"},"headshot_url":null},{"person_slug":"sandi-see-tai-m-d-lxeo","display_name":"Sandi See Tai, M.D.","role_category":"executive","title":"Chief Development Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.94,"evidence":{"document_title":"LXEO executive roster source","source_url":null,"source_type":"sec_filing","published_at":null,"effective_date":"2026-05-03","last_checked_at":"2026-05-03T15:43:29.420225+00:00"},"headshot_url":null}],"coverage":{"schema_version":"alpha-leadership-coverage-v1","board_roster_scope":"def_14a_current_directors","executive_roster_scope":"disclosed_officers_only","neo_set_status":"NOT_ASSERTED","board_roster_complete":false,"neo_set_complete":false,"notes":["Empty executives is NOT_ASSERTED, not a complete named-executive-officer set.","Form 4 occupancy is not a DEF 14A board.","Unconfirmed current sec_proxy DEF 14A directors may project. Confirmed is not required.","Unconfirmed current executives with first-party issuer evidence (source_url + effective date) may project.","Company-page directors do not require people.public_profile_enabled.","Completeness compares the latest first-party roster with the public projection; a source older than 180 days is STALE.","Do not remap HONA to HON 0000773840. Do not merge XOM 0000034088 with 0002115436.","Person match is projection-only. Name-only Person merges are forbidden."],"completeness":{"reasons":["NO_LEADERSHIP_SOURCE"],"board_completeness":"NOT_REVIEWED","completeness_schema":"alpha-leadership-completeness-v1","executive_team_completeness":"NOT_REVIEWED"},"parser_bleed_excluded":true,"former_titles_excluded":true,"identity_merge_forbidden":true,"form4_occupancy_is_not_board":true}},"governance":{"summary":"Current confirmed board seats plus verified executive Claims. Committees appear only when membership is stored on a current role.","boundary":"Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. Empty executives is NOT_ASSERTED, not a complete NEO set. Form 4 occupancy is not a DEF 14A board. Chair is never inferred from list order. Person identities are not merged on name.","committees":[],"disclosures":[]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"structured_data":{"@context":["https://schema.org",{"alpha":"https://alpha.ac/ns/","indexMembership":"alpha:indexMembership","indexProvider":"alpha:indexProvider","indexMembershipStatus":"alpha:indexMembershipStatus","indexEffectiveDate":"alpha:indexEffectiveDate","indexAnnouncementDate":"alpha:indexAnnouncementDate","indexRemovalDate":"alpha:indexRemovalDate","lastVerifiedAt":"alpha:lastVerifiedAt","verificationStatus":"alpha:verificationStatus","evidence":"alpha:evidence"}],"@type":"ProfilePage","@id":"https://registry.alpha.ac/companies/lexeo-therapeutics-inc#profile","url":"https://registry.alpha.ac/companies/lexeo-therapeutics-inc","dateModified":"2026-10-06T04:46:47.792621+00:00","mainEntity":{"@type":"Organization","@id":"https://registry.alpha.ac/companies/lexeo-therapeutics-inc#organization","legalName":"Lexeo Therapeutics, Inc.","name":"Lexeo Therapeutics, Inc.","url":"https://registry.alpha.ac/companies/lexeo-therapeutics-inc","addressCountry":"US","indexMembership":[],"member":[{"@type":"OrganizationRole","roleName":"Chairman of the Board","member":{"@type":"Person","name":"Steven Altschuler, M.D.","url":"https://registry.alpha.ac/people/steven-altschuler-m-d"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2023-01-01","member":{"@type":"Person","name":"Brenda Cooperstone","url":"https://registry.alpha.ac/people/brenda-cooperstone-lxeo"}},{"@type":"OrganizationRole","roleName":"Director","member":{"@type":"Person","name":"Brenda Cooperstone, M.D.","url":"https://registry.alpha.ac/people/brenda-cooperstone-m-d-lexeo-therapeutics-inc"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2026-01-01","member":{"@type":"Person","name":"Laura Sepp-Lorenzino","url":"https://registry.alpha.ac/people/laura-sepp-lorenzino-lxeo"}},{"@type":"OrganizationRole","roleName":"Director","member":{"@type":"Person","name":"Laura Sepp-Lorenzino, Ph.D.","url":"https://registry.alpha.ac/people/laura-sepp-lorenzino-ph-d"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2020-01-01","member":{"@type":"Person","name":"Mette Kirstine Agger","url":"https://registry.alpha.ac/people/mette-kirstine-agger-lxeo"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2021-01-01","member":{"@type":"Person","name":"Paula HJ Cholmondeley","url":"https://registry.alpha.ac/people/paula-hj-cholmondeley-lxeo"}},{"@type":"OrganizationRole","roleName":"Chief Executive Officer and Director","member":{"@type":"Person","name":"R. Nolan Townsend","url":"https://registry.alpha.ac/people/r-nolan-townsend-lxeo"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2005-01-01","member":{"@type":"Person","name":"Reinaldo Diaz","url":"https://registry.alpha.ac/people/reinaldo-diaz-lxeo"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2012-01-01","member":{"@type":"Person","name":"Steven Altschuler","url":"https://registry.alpha.ac/people/steven-altschuler-lxeo"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2024-01-01","member":{"@type":"Person","name":"Tim Van Hauwermeiren","url":"https://registry.alpha.ac/people/tim-van-hauwermeiren-lxeo"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2024-01-01","member":{"@type":"Person","name":"Tolga Tanguler","url":"https://registry.alpha.ac/people/tolga-tanguler-lxeo"}},{"@type":"OrganizationRole","roleName":"Chief Medical Officer and Head of Research","member":{"@type":"Person","name":"Eric Adler, M.D.","url":"https://registry.alpha.ac/people/eric-adler-m-d-lxeo"}},{"@type":"OrganizationRole","roleName":"Chief Legal Officer","member":{"@type":"Person","name":"Jenny R. Robertson, J.D.","url":"https://registry.alpha.ac/people/jenny-r-robertson-j-d-lxeo"}},{"@type":"OrganizationRole","roleName":"Chief Operating Officer","startDate":"2026-04-30","member":{"@type":"Person","name":"Jose Manuel Otero","url":"https://registry.alpha.ac/people/jose-manuel-otero"}},{"@type":"OrganizationRole","roleName":"Chief Operating Officer","member":{"@type":"Person","name":"Jose Manuel Otero, Ph.D.","url":"https://registry.alpha.ac/people/jose-manuel-otero-ph-d-lxeo"}},{"@type":"OrganizationRole","roleName":"Chief Financial Officer","member":{"@type":"Person","name":"Kyle Rasbach, Ph.D.","url":"https://registry.alpha.ac/people/kyle-rasbach-ph-d-lxeo"}},{"@type":"OrganizationRole","roleName":"Chief Financial Officer","member":{"@type":"Person","name":"Louis Tamayo","url":"https://registry.alpha.ac/people/louis-tamayo"}},{"@type":"OrganizationRole","roleName":"Chief Medical Officer","member":{"@type":"Person","name":"Narinder Bhalla, M.D.","url":"https://registry.alpha.ac/people/narinder-bhalla-m-d"}},{"@type":"OrganizationRole","roleName":"Chief Medical Officer","startDate":"2026-04-30","member":{"@type":"Person","name":"Narinder P. Bhalla","url":"https://registry.alpha.ac/people/narinder-p-bhalla"}},{"@type":"OrganizationRole","roleName":"Chief Executive Officer","member":{"@type":"Person","name":"R. Nolan Townsend","url":"https://registry.alpha.ac/people/r-nolan-townsend-lxeo"}},{"@type":"OrganizationRole","roleName":"Chief Development Officer","member":{"@type":"Person","name":"Sandi See Tai, M.D.","url":"https://registry.alpha.ac/people/sandi-see-tai-m-d-lxeo"}}]},"mainEntityOfPage":"https://registry.alpha.ac/companies/lexeo-therapeutics-inc"},"financials":{"kind":"financials","records":[],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"},"ownership":{"kind":"ownership","records":[],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented. 13F and N-PX are not beneficial ownership and are never projected here.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"},"registry_intelligence":{"schema_version":"alpha-registry-intelligence-v1","record_version":"d751713988987e9331980363e24189ce","subject":"alpha:company:lexeo-therapeutics-inc","as_of":"2026-10-06T20:07:47.497441+00:00","recorded_at":"2026-10-06T20:07:47.497441+00:00","availability":"available","records":[],"next_offset":null,"limitations":["Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage."]},"risk_oversight":{"schema_version":"alpha-risk-oversight-v1","subject":"alpha:company:lexeo-therapeutics-inc","record_version":"d751713988987e9331980363e24189ce","as_of":"2026-10-06T20:07:47.495703+00:00","recorded_at":"2026-10-06T20:07:47.495703+00:00","availability":"available","complete":true,"records":[],"limitations":["Only explicitly reviewed, rights-cleared assignments, in the company's own wording.","An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence."]}},"canonical_source":"aegis_canonical","registry_intelligence":{"schema_version":"alpha-registry-intelligence-v1","record_version":"d751713988987e9331980363e24189ce","subject":"alpha:company:lexeo-therapeutics-inc","as_of":"2026-10-06T20:07:47.497441+00:00","recorded_at":"2026-10-06T20:07:47.497441+00:00","availability":"available","records":[],"next_offset":null,"limitations":["Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage."]},"risk_oversight":{"schema_version":"alpha-risk-oversight-v1","subject":"alpha:company:lexeo-therapeutics-inc","record_version":"d751713988987e9331980363e24189ce","as_of":"2026-10-06T20:07:47.495703+00:00","recorded_at":"2026-10-06T20:07:47.495703+00:00","availability":"available","complete":true,"records":[],"limitations":["Only explicitly reviewed, rights-cleared assignments, in the company's own wording.","An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence."]}}